Clinical Chemistry

In Other News

• International Experts Recommend Ending Routine 'Corrected' Calcium Reporting

• Long-Term Data Show PSA Screening Modestly Reduces Prostate Cancer Deaths

• Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively

• Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

• FDA-Cleared Assay Enables Comprehensive Automated Testosterone Testing

• CE-Marked Blood Biomarker Test Advances Automated Alzheimer’s Diagnostics

• Noninvasive Urine Test May Support Earlier Diagnosis of Psychiatric Disorders

• At-Home Blood and Cognitive Tests Support Dementia Risk Stratification

• Ultrasensitive Test Detects Key Biomarker of Frontotemporal Dementia Subtype

• Routine Blood Tests Years Before Pregnancy Could Identify Preeclampsia Risk

• Blood Test Detects Testicular Cancer Missed by Standard Markers

• Routine Blood Tests Identify Biomarkers Linked to PTSD

• Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

• Routine Blood Count Ratio Linked to Future Alzheimer’s and Dementia Risk

• Label-Free Microfluidic Device Enriches Tumor Cells and Clusters from Pleural Effusions

• Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

• Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

• Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

• Study Finds ApoB Testing More Effective Than LDL for Guiding Lipid Therapy

• AI-Enabled POC Test Quantifies Multiple Cardiac Biomarkers

• Next Generation Automated Analyzers Increase Throughput for Clinical Chemistry and Electrolyte Testing

• Blood Metabolite Test Detects Early Cognitive Decline

• AI-Based Blood Test Diagnose Multiple Brain Disorders from Blood Sample